García, F., Bernaldo de Quirós, J. C. L., Gómez, C. E., Perdiguero, B., Nájera, J. L., Jiménez, V., . . . Esteban, M. (2011). Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02).
Chicago Style CitationGarcía, Felipe, et al. Safety and Immunogenicity of a Modified Pox Vector-based HIV/AIDS Vaccine Candidate Expressing Env, Gag, Pol and Nef Proteins of HIV-1 Subtype B (MVA-B) in Healthy HIV-1-uninfected Volunteers: A Phase I Clinical Trial (RISVAC02). 2011.
MLA CitationGarcía, Felipe, et al. Safety and Immunogenicity of a Modified Pox Vector-based HIV/AIDS Vaccine Candidate Expressing Env, Gag, Pol and Nef Proteins of HIV-1 Subtype B (MVA-B) in Healthy HIV-1-uninfected Volunteers: A Phase I Clinical Trial (RISVAC02). 2011.